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Introduction
Using first-pass MRA (FP-MRA) spatial resolution is
limited by breath-hold duration, and image quality (IQ)
may be hampered by motion artefacts. Studies at 1.5 T
have shown that the use of blood-pool contrast agents
(BP-CA) allows for motion-compensated high-resolution
MRA during the steady-state, yielding significantly
higher IQ compared to FP-MRA. However, MRA with
BP-CAs does not allow for viability imaging. At 3 T the
use of a slowly injected extracellular CA at double dose
may allow for a high-resolution MRA (HR-MRA) AND
viability imaging.
Purpose
The purpose of this study was 1) to implement an ECG-
gated free breathhing HR-MRA protocol using an extra-
cellular CA (Gadobutrol) at 3 T and 2) to compare the
vessel sharpness and image quality of standard FP-MRA
to HR-MRA of the thoracic vasculature in children and
adolescents with congenital disorders (CD) or acquired
disease (AD) of the thoracic vasculature.
Methods
To date, 13 Patients (age range: 5 to 41 years) with CD
or AD of the thoracic vasculature underwent both,
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Figure 1 A: FF-MRA B: HR-MRA.
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MRA imaging was part of a comprehensive imaging
protocol including viability imaging for assessment of
CD and AD. Vessel sharpness of left pulmonary artery
(LPA), left superior pulmonary vein (LSPV) and aorta
ascendens (AA) were calculated. Furthermore, image
quality was rated independently by two readers using a
four point grading scale (1: no image artefacts and
excellent vessel sharpness; 4) severe artefacts with poor
vessel delineation).
Results
HR-MRA yielded significantly higher vessel sharpness
for LSPV (FP-MRA: 0.38 ± 0.11 vs. HR-MRA: 0.57 ±
0.12), LPA (FP-MRA: 0.37 ± 0.06 vs. HR-MRA: 0.50 ±
0.11) and AA (FP-MRA: 0.50 ± 0.10 vs. HR-MRA: 0.74
± 0.15) compared to the FP-MRA. Image quality was
rated higher for HR-MRA compared to FP-MRA by
both reviewers. Typical images are displayed in Figure 1,
demonstrating the advantage of motion-compensated
HR-MRA (B) vs. FP-MRA (A).
Conclusions
HR-MRA of the thoracic vasculature using extracellular
CA offers superior vessel sharpness and improved image
quality compared to standard FP-MRA at 3 T. Thus
H R - M R Am a yb eu s e da sa na d d - o nt os t a n d a r dF P -
MRA. Due to the inherent delayed data acquisition of
viability imaging in combination with double dose CA
regimen, HR-MRA does not require additional scanning
time or contrast agent injection.
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